Skip to main content

Table 2 NGS accuracy sample results

From: A direct comparison of next generation sequencing enrichment methods using an aortopathy gene panel- clinical diagnostics perspective

#

Sample

Mutations

Coverage RDa (% mutant allele)

Coverage SSa (% mutant allele)

Mean coverage

Other information

1

FBN1 Positive

c.1585C>T, p.R529X

101x (47%)

576x (60%)

1477x (RD) 508x (SS)

In COL3A1, c.198A>G, p.I66M, a novel change.

2

TGFBR1 Positive

c.799A>G, p.N267D

317x (51%)

504x (58%)

462x (RD) 563x (SS)

 

3

TGFBR2 Positive

c.1583G>A, p.R528H

183x (48%)

257x (50%)

177x (RD) 499x (SS)

 

4

MYH11 Positive

IVS32+1C>A (splice)

71x (58%)

80x (50%)

140x (RD) 164x (SS)

 

5

Symptomatic unknown

No mutations found.

NA

NA

33x (RD) 260x (SS)

In SLC2A10 p.A206T (rs#2235491) and p.A385G (rs#79849424). In NOTCH1, IVS16-4C>CT (rs#3125001).

6

Symptomatic unknown

COL3A1 IVS9-7T>C novel change; potential splice site variant

48x (56%)

416x (50%)

86x (RD) 355x (SS)

In COL3A1, p.A698T (rs#1800255). In FBN2, p.V965I (rs#154001).

7

FBN1 Coriell positive

Unable to confirm due to sample quality.

Failed merge between DNA and primer library droplets

Poor data due to low quality DNA

NA

 

8

Healthy Control

No mutations found

NA

Failed due pipetting error

340x (RD)

 
  1. aRainDance (RD) and SureSelect (SS). All variants reported in this table are heterozygous as confirmed by Sanger sequencing (data not shown). NA, not applicable.